Prescribing information for GLP-1 receptor agonists describes several circumstances in which these medications should not be used or should be approached with caution, and a responsible screening process is designed to surface every one of them
Making another peptide would not be a huge leap
Original or Review : Is the paper an original study, randomized trial, cohort study, systematic review, meta-analysis, or narrative review focused on GLP-1 research
SkinnyRx does not require lab work
A proper GLP-1 evaluation should include: A complete medical history and review of current medications BMI and body composition assessment Blood work including metabolic panel, HbA1c, lipid panel, and thyroid function Cardiovascular risk assessment Discussion of realistic expectations, side effect management, and a plan for nutritional support Be cautious of any service that prescribes GLP-1 medications after a brief online questionnaire with no physician review